GSK has developed a new propellant ... 35 million people with asthma around the world. Inhalers are also a major contributor to the carbon footprint of healthcare systems, according to the company.

Lockheed Martin lays off 64 Mass. clean energy workers Lockheed Martin lays off 64 Mass. clean energy workers © 2025 American ...

The vaccine is based on Affinivax' multiple antigen presenting system, or MAPS, which combines ... and broadens GSK's existing scientific footprint in the Boston area," said GSK's R&D chief ...

GSK plc (LSE/NYSE:GSK ... SLD, affecting up to 5% of the global population, is characterized by the accumulation of fat in the liver, leading to inflammation and fibrosis. Efimosfermin, a once ...

GSK plc (LSE/NYSE:GSK), a leading pharmaceutical company, announced today the appointment of Dr. Gavin Screaton to its Board of Directors. With this new role, Dr. Screaton has acquired 8,675 ...

Pegylated Interferons: Still a Major Player for the Treatment of Myeloproliferative Neoplasms Bispecific antibodies have ushered in a transformative era in treating non–small cell lung cancer (NSCLC), ...

But an interactive map we developed, alongside an international team of scientists from the University of Queensland and Duke University and in partnership with the Global Ocean Biodiversity ...

Broadening eligibility criteria and decentralizing trial designs can improve the inclusion of real-world patient populations often underrepresented in research. Patient advocacy organizations play a ...

Xpertnest’s corporate bond listing on a global stock exchange in August 2023 further solidified investor ... with a robust project pipeline and a growing global footprint. ... GSK plc 1,450.18 +0.14% ...